A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

检 索： 期刊全称 刊名关键词 ISSN         高级检索

期刊名称：EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH ISSN： 1473-7167 出版频率： Bi-monthly 出版社： TAYLOR & FRANCIS LTD, 2-4 PARK SQUARE, MILTON PARK, ABINGDON, England, OXON, OX14 4RN   出版社网址： http://www.expert-reviews.com/ 期刊网址： http://www.expert-reviews.com/loi/erp 影响因子： 2.217 (2020年) 1.828(2018年) 1.797(2017年) 1.780(2016年) 1.631(2015年) 1.669(2014年) 1.87(2013年) 1.674 (2012年) 主题范畴： HEALTH POLICY & SERVICES 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal         Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author's most critical points Indexing Impact Factor: 1.674 (2012) CINAHL®Plus Current Contents®/Clinical Medicine Current Contents®/Social and Behavioral Sciences EMBASE/Excerpta Medica EMCare Journal Citation Reports/ Social Sciences Edition Journal Citation Reports/Science Edition® MEDLINE/Index Medicus Science Citation Index Expanded™ (SciSearch®) Scopus Social Scisearch®   Instructions to Authors EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH.pdf Editorial Board Senior Editor Bottomley A, EORTC, Belgium Associate Editors Cleeland C, MD Anderson Cancer Center, TX, USA Flechtner H-H, University of Magdeburg, Germany Gotay C, University of British Columbia, Canada Taphoorn MJB, Medical Centre Haaglanden, The Netherlands Editorial Board Aaronson NK, The Netherlands Cancer Institute, The Netherlands Annemans L, University of Ghent, Belgium Ashcroft DM, University of Manchester, UK Awad AG, University of Toronto, Canada Badia X, Global Leader Observational COE, Senior Principal HEOR, IMS Health, Spain Bridges J, Johns Hopkins University, MD, USA Brixner D, University of Utah, UT, USA Cella D, Northwesern University, IL, USA Chow E, Sunnybrook Regional Cancer Center, CA, USA Coens C, EORTC, Belgium DeKoven MP, IMS Health, Inc., VA, USA Ferreira PL, Universidade Coimbra, Portugal Gans-Combe C, Reihoo, France Greimel E, University of Graz, Austria Hartzema AG, University of Florida, FL, USA Ikegami N, Keio University, Japan LeGrand C, Univ. Catholique de Louvain, Belgium Khan ZM, Vice President Pricing and Market Access, Celgene Corporation, NJ, USA  King M, University of Sydney, Australia Krabbe PFM, University Medical Center Groningen, The Netherlands Minshall ME, Director, Healthcare Economics & Outcomes Research, Covidien, MA, USA Motheral B, President, CareScientific LLC, TN, USA Neumann PJ, Tufts University School of Medicine, MA, USA Pavlovic M, AFSSAPS, France Postma M, Groningen University, The Netherlands Raisch DW, University of New Mexico, NM, USA Ramjiawan B, St Boniface General Hospital Research Centre, Canada Ramsey S, Fred Hutchinson Cancer Research Center, WA, USA Rubenstein L, University of California Los Angeles, USA Sculpher M, University of York, UK Sendi P, University of Basel, Switzerland Shaya FT, University of Maryland, MD, USA Simoens S, Katholieke Universiteit Leuven, Belgium Sloan J, Mayo Clinic/Medical School, MN, USA Snyder C, Johns Hopkins University, MD, USA Summers KH, Purdue University School of Pharmacy, IN, USA Torigoe Y, Principle PRO Scientist Oncology, Genentech Inc., CA, USA  Wilson L, University of California San Francisco, CA, USA Younis MZ, Jackson State University, FL, USA